Calumet Specialty Products Partners, LP produces and sells specialty hydrocarbon products in North America and internationally. The company is headquartered in Indianapolis, Indiana.
98 articles
Calumet Specialty Products Partners shares reached an all-time high of $58.44, marking a nearly 210% increase over the past year despite concerns of being overvalued.
BlueCrest Capital Management increased its stake in Calumet Specialty Products Partners by 33.3%, purchasing 20,000 shares valued at $2.88 million. The stock rose 3.3% amid broader institutional inter
Calumet Specialty Products Partners stock reached a 52-week high of $54.72, surging over 200% annually despite mixed Q2 2026 results. S&P Global Ratings upgraded the firm to 'B-' alongside updated pri
UBS Asset Management Americas increased its stake in Calumet, Inc. by 19.5% in Q2, now holding shares valued at $5.6 million. The company reported 40.8% year-over-year revenue growth despite missing e
Concurrent Investment Advisors LLC acquired 57,380 shares of Calumet Specialty Products Partners worth approximately $2.07 million in Q2. Institutional holdings total 34.41%, though the company report
Legal & General Group Plc acquired a 0.06% stake in Calumet Specialty Products Partners for approximately $1.73 million. Despite strong revenue growth, Calumet missed earnings estimates, leading to mi
Manufacturers Life Insurance Company invested $1.07 million acquiring 29,852 shares of Calumet Specialty Products Partners. Institutional holdings stand at 34.41%, though analyst ratings remain mixed
Wellington Management Group LLP reduced its stake in Calumet, Inc. by 2.3% in Q2, selling 19,076 shares while retaining holdings worth $29.2 million despite mixed analyst sentiment.
HC Wainwright raised its price target for Calumet Specialty Products Partners to $75, citing a 40.8% year-over-year revenue increase. Despite missing earnings expectations, the firm maintains a buy ra
Analysts assigned Calumet, Inc. a 'Hold' rating with a $48 target despite 40.8% revenue growth. The company missed earnings, though institutional investors significantly increased their positions.
Calumet Specialty Products Partners stock hit a 52-week high of $51.51, driven by strong Q2 results and performance in specialty oils and renewable fuels.
Calumet Specialty Products Partners reached a new 52-week high of $51.57 despite an adjusted loss of $1.09 per share. Quarterly revenue rose 40.8% year-over-year to $1.45 billion, while analysts maint
S&P Global Ratings upgraded Calumet Specialty Products Partners' credit rating to "B-", citing strong first-half 2026 earnings and performance in specialty oils and renewable fuels. The stable outlook
UBS raised its price target for Calumet Specialty Products Partners to $47 from $26, maintaining a Neutral rating. This update reflects an improved analyst outlook on the oil and gas refining company.
Calumet Specialty Products Partners announced plans to attend the Barclays 40th Annual Energy-Power Conference on September 10, 2026, for investor meetings. The company manufactures specialty branded
Calumet Inc shares fell 3.5% to $47.28, though GuruFocus assesses the stock as significantly overvalued by 159.4%. The company remains unprofitable with negative cash flow and notable insider selling.
Two Seas Capital LP acquired over 6.6 million shares worth $238.4 million in Calumet, Inc., making it their third-largest holding. Despite revenue growth, the company missed earnings estimates, mainta
Calumet Specialty Products Partners director John G. Boss filed Form 4 reports detailing acquisitions of restricted stock units. The transactions were grants with no cost basis and include vesting con
Calumet Director Stephen P. Mawer reported two transactions involving Restricted Stock Units (RSUs) on August 20, 2026. The filings were made to the SEC via Form 4, indicating equity compensation awar
Calumet Director Amy M. Schumacher reported two transactions involving 650 Restricted Stock Units (RSUs) via Form 4 SEC filing. The grants were valued at $0.00 with vesting conditions extending to Jul
one8zero8 LLC purchased 186,020 shares of Calumet Specialty Products Partners valued at $6.7 million. While Q2 revenue increased 40.8%, the company missed earnings expectations, leading to a mixed ana
Calumet Inc shares rose 5.1%, but GuruFocus rates the stock significantly overvalued at $50.81 against an intrinsic value of $18.23. Concerns over unprofitability and insider selling advise investor c
Calumet Specialty Products Partners stock reached a new 52-week high of $49.17, boosting market cap to $4.31 billion despite a Q2 adjusted EPS loss. TD Cowen raised its price target to $40 while maint
Calumet Specialty Products Partners reported increased Q2 sales but a wider first-half net loss driven by profitability pressures. Its investment strategy hinges on shifting to renewables and specialt
Russell Investments Group Ltd. increased its stake in Calumet Specialty Products Partners by 239.4%, purchasing 30,990 shares. Calumet reported a 40.8% revenue increase but missed earnings expectation
Two Seas Capital LP reported a 7.5% beneficial ownership stake in Calumet Specialty Products Partners via its Two Seas Global Fund. The Schedule 13G/A filing indicates sole voting power over approxima
Wasserstein Management L.P. disclosed a 4.6% beneficial ownership stake in Calumet Specialty Products Partners via an amended Schedule 13G filing on June 30, 2026. The holding comprises approximately
Bank of America increased its stake in Calumet Specialty Products Partners by 65.1% in Q1. Calumet reported a 40.8% revenue increase but missed earnings estimates with an adjusted loss.
Calumet Specialty Products Partners faces mixed valuation signals as Strait of Hormuz tensions drive up Brent crude prices. Analysts debate whether the stock is overvalued at $47.19 due to debt and re
TD Cowen maintained a Hold rating on Calumet Specialty Products Partners while raising its price target to $40.00, though analysts note significant overvaluation and insider selling concerns.
ChemBrief